BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34460962)

  • 21. Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C.
    Li Z; Zhang Y; An J; Feng Y; Deng H; Xiao S; Ji F
    J Clin Virol; 2014 Jul; 60(3):190-5. PubMed ID: 24830933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of herpes zoster and chronic inflammatory skin disease in US inpatients.
    Chovatiya R; Silverberg JI
    J Am Acad Dermatol; 2021 Dec; 85(6):1437-1445. PubMed ID: 31958523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus infection prevalence in lichen planus: examination of lesional and normal skin of hepatitis C virus-infected patients with lichen planus for the presence of hepatitis C virus RNA.
    Erkek E; Bozdogan O; Olut AI
    Clin Exp Dermatol; 2001 Sep; 26(6):540-4. PubMed ID: 11678885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy.
    Berk DR; Mallory SB; Keeffe EB; Ahmed A
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):142-51. PubMed ID: 16919505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of hepatitis C virus (HCV) RNA in the lesions of lichen planus in patients with chronic hepatitis C: detection of anti-genomic- as well as genomic-strand HCV RNAs in lichen planus lesions.
    Kurokawa M; Hidaka T; Sasaki H; Nishikata I; Morishita K; Setoyama M
    J Dermatol Sci; 2003 Jun; 32(1):65-70. PubMed ID: 12788531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus Ribavirin.
    Wu CM; Su FH; Muo CH; Huang JC; Wu MM; Yeh CC
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33799370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis.
    Lodi G; Pellicano R; Carrozzo M
    Oral Dis; 2010 Oct; 16(7):601-12. PubMed ID: 20412447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus chronic infection and oral lichen planus: an Italian case-control study.
    Giuliani M; Lajolo C; Miani MC; Lodi G; Minenna P; Mangia A
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):647-52. PubMed ID: 17625433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-free therapy with sofosbuvir plus ribavirin for successful treatment of genotype 2 hepatitis C virus with lichen planus: a case report.
    Yoshikawa A; Terashita K; Morikawa K; Matsuda S; Yamamura T; Sarashina K; Nakano S; Kobayashi Y; Sogabe S; Takahashi K; Haba S; Oda H; Takahashi T; Miyagishima T; Sakamoto N
    Clin J Gastroenterol; 2017 Jun; 10(3):270-273. PubMed ID: 28447325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral diseases associated with hepatitis C virus infection. Part 2: lichen planus and other diseases.
    Carrozzo M
    Oral Dis; 2008 Apr; 14(3):217-28. PubMed ID: 18221456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Treated and Untreated Chronic Hepatitis C With the Incidence of Active Tuberculosis Disease: A Population-Based Cohort Study.
    Baliashvili D; Blumberg HM; Benkeser D; Kempker RR; Shadaker S; Averhoff F; Gvinjilia L; Adamashvili N; Magee M; Kamkamidze G; Zakalashvili M; Tsertsvadze T; Sharvadze L; Chincharauli M; Tukvadze N; Gandhi NR
    Clin Infect Dis; 2023 Jan; 76(2):245-251. PubMed ID: 36134743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.
    Giordanino C; Bugianesi E; Smedile A; Ciancio A; Abate ML; Olivero A; Pellicano R; Cassader M; Gambino R; Bo S; Ciccone G; Rizzetto M; Saracco G
    Am J Gastroenterol; 2008 Oct; 103(10):2481-7. PubMed ID: 18702647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lichen planus associated with hepatitis C virus: no viral transcripts are found in the lichen planus, and effective therapy for hepatitis C virus does not clear lichen planus.
    Harden D; Skelton H; Smith KJ
    J Am Acad Dermatol; 2003 Nov; 49(5):847-52. PubMed ID: 14576663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term impact of certain coexisting extrahepatic unisystem and multisystem manifestations on trends in incidence of liver cirrhosis in treatment-naïve patients with chronic hepatitis C: A nested case-control study.
    Wang CH; Ou SF; Tseng YT
    Medicine (Baltimore); 2022 Jul; 101(29):e29697. PubMed ID: 35866797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism.
    Su TH; Yang HC; Tseng TC; Chou SW; Lin CH; Liu CH; Liu CJ; Chen CL; Kao JH
    Mov Disord; 2019 Dec; 34(12):1882-1890. PubMed ID: 31505068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between treatment of hepatitis C virus and risk of cardiovascular disease among insured patients with the virus in the United States.
    Wang W; Chen C; Re VL; Chang SH; Wilson DL; Park H
    Pharmacoepidemiol Drug Saf; 2023 Oct; 32(10):1142-1151. PubMed ID: 37278688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES).
    Butt AA; Yan P; Aslam S; Shaikh OS; Abou-Samra AB
    Clin Infect Dis; 2020 Mar; 70(6):1153-1160. PubMed ID: 30977808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients.
    Hsu CS; Huang CJ; Kao JH; Lin HH; Chao YC; Fan YC; Tsai PS
    PLoS One; 2013; 8(7):e70458. PubMed ID: 23894660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection.
    Su TH; Liu CJ; Tseng TC; Chou SW; Liu CH; Yang HC; Wu SJ; Chen PJ; Chen DS; Chen CL; Kao JH
    Aliment Pharmacol Ther; 2019 Feb; 49(3):331-339. PubMed ID: 30592071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermatologic manifestations of hepatitis C infection and the effect of interferon therapy: a literature review.
    Jadali Z
    Arch Iran Med; 2012 Jan; 15(1):43-8. PubMed ID: 22208443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.